RIVER EDGE, N.J.--(BUSINESS WIRE)--Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, announced today the appointment of Moshe Pinto, to its Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
